Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • ONS Congress
    • COVID-19
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Once a Nurse, Always a Nurse
    COVID-19
    Once a Nurse, Always a Nurse
    April 01, 2020
    Nurses Always Find a Way to Communicate Care to Patients Who Don’t Speak Our Language
    Oncology nurse-patient relationship
    Nurses Always Find a Way to Communicate Care to Patients Who Don’t Speak Our Language
    March 27, 2020
    Patient Communication Strategies for COVID-19 Conversations
    COVID-19
    Patient Communication Strategies for COVID-19 Conversations
    March 26, 2020
    Use This Guide to Navigate Difficult Conversations
    Difficult decisions
    Use This Guide to Navigate Difficult Conversations
    March 20, 2020
    End-of-Life Care Helps Patients Pursue Purpose in the Presence of Pain
    End of life (EOL)
    End-of-Life Care Helps Patients Pursue Purpose in the Presence of Pain
    March 13, 2020
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Genomic Classifier Predicts Breast Cancer Radiation Benefit, Recurrence Risk
    Breast cancer

    Genomic Classifier Predicts Breast Cancer Radiation Benefit, Recurrence Risk

    The Adjuvant Radiotherapy Intensification Classifier (ARTIC) predicts which women with early-stage breast cancer will benefit the most from radiotherapy, as well as their risk for locoregional recurrence after radiation, researchers reported in study findings published in the Journal of Clinical Oncology. 

    March 30, 2020
    Prostate Cancer Disparities Disappear With Equal Access to Care
    Cancer health disparities

    Prostate Cancer Disparities Disappear With Equal Access to Care

    Typically, African American men have worse outcomes from prostate cancer than their white counterparts. But according to the results of a new study in patients in the U.S. Department of Veterans Affairs (VA) health system where all patients have equal access to care, no disparities exist between the two groups—in fact, the African American men in the VA system had better outcomes than non-Hispanic whites. The findings were reported in Cancer.  

    March 27, 2020
    Pembrolizumab Is More Cost Effective Than Atezolizumab for NSCLC
    Oncology drug research

    Pembrolizumab Is More Cost Effective Than Atezolizumab for NSCLC

    Adding atezolizumab to treatment with bevacizumab, carboplatin, and paclitaxel as first-line therapy for metastatic, nonsquamous non-small cell lung cancer (NSCLC) is associated with survival benefit—but it comes at a cost, researchers said in study results published in JAMA Network Open. In comparison, pembrolizumab offers a more cost-effective survival benefit. 

    March 25, 2020
    Radiation Unnecessary for Children With ALL
    Radiation therapy

    Radiation Unnecessary for Children With ALL

    Children with acute lymphoblastic leukemia (ALL) at risk for cancer recurrence in the brain don’t need prophylactic radiation therapy, researchers reported in the Journal of Clinical Oncology. 

    March 18, 2020
    U.S. Still Has Declining Cancer Death Rates, Latest National Report Says
    Research

    U.S. Still Has Declining Cancer Death Rates, Latest National Report Says

    Overall cancer death rates fell 1.5% on average per year from 2001–2017 in the United States for all cancer sites combined, according to the Annual Report to the Nation on the Status of Cancer from the Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), American Cancer Society, and North American Association of Central Cancer Registries.

    March 16, 2020
    Oncolytic Virus Kills Tumor Cells While Supporting T Cells
    Research

    Oncolytic Virus Kills Tumor Cells While Supporting T Cells

    A new type of dual-function oncolytic virus that simultaneously kills cancer cells while increasing levels of leptin to support T cells is showing promise in melanoma mouse models, researchers reported in Immunity.   

    March 11, 2020
    Educational Framework Offers Guidance for Oral Chemo Safety at Home
    Safety

    Educational Framework Offers Guidance for Oral Chemo Safety at Home

    One aspect that ambulatory oncology nurses must consider in the greater staffing conversation is the time spent on educating patients and caregivers about oral chemotherapy safety in the home setting. Developing an educational framework to guide those conversations not only ensures that all critical information is covered but also that it’s delivered in a standard and efficient process. 

    March 10, 2020
    Smoking Rates Are Low, But Here’s How They Can Be Lower
    Lung Cancer

    Smoking Rates Are Low, But Here’s How They Can Be Lower

    Although U.S. smoking rates have hit an all-time low of 14%, 34 million American adults are still considered active smokers, according to the U.S. surgeon general’s January 2020 report on smoking cessation. It’s the first new report focused directly on smoking cessation from the surgeon general’s office in 30 years. 

    March 04, 2020
    Cancer Death Rates See Largest-Ever Single-Year Drop
    American Cancer Society (ACS)

    Cancer Death Rates See Largest-Ever Single-Year Drop

    Overall U.S. cancer mortality fell 2.2% from 2016 to 2017, the largest reduction for a single year, according to the American Cancer Society’s “Cancer Statistics, 2020,” published in CA: A Cancer Journal for Clinicians.

    February 26, 2020
    HPV Vaccine Has an Indirect Benefit: Herd Immunity
    Research

    HPV Vaccine Has an Indirect Benefit: Herd Immunity

    As more people receive the human papillomavirus (HPV) vaccine to protect themselves from strains of the virus that can cause cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers, researchers are starting to see herd immunity, where even people who haven’t received the vaccine are developing fewer oral HPV infections. The findings were published in JAMA.

    February 19, 2020
    Women With Diabetes Are Less Likely to Get Cancer Screenings
    Research

    Women With Diabetes Are Less Likely to Get Cancer Screenings

    Modest differences may exist among women with diabetes compared to healthy controls when it comes to adhering to screening recommendations for breast, cervical, and colorectal cancers, according to results of a study published in Diabetologia.

    February 12, 2020
    Immune-Related Adverse Events With PD-1 Inhibitors in Head and Neck Cancer
    Clinical practice

    Immune-Related Adverse Events With PD-1 Inhibitors in Head and Neck Cancer

    Clinical trial results show that PD-1 inhibitors offer improved survival and a better safety profile compared to standard, single-agent chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. However, because of their mechanism of action as immunotherapy, patients receiving the agents may experience immune-related adverse events (irAEs).

    February 11, 2020
    Blood Test May Show Earliest Warning of Breast Cancer
    Research

    Blood Test May Show Earliest Warning of Breast Cancer

    Identifying a panel of tumor-associated antigens and autoantibodies through a simple blood test may one day help providers diagnose the earliest stages of breast cancer, before clinical signs appear.

    February 05, 2020
    Study Drug Plus Immunotherapy May Offer New Treatment Option for Lung and Kidney Cancer
    Treatments

    Study Drug Plus Immunotherapy May Offer New Treatment Option for Lung and Kidney Cancer

    Pegilodecakin, an investigational, first-in-class drug currently in clinical trials, is demonstrating positive safety results and measurable responses when used in combination with pembrolizumab or nivolumab in patients with non-small cell lung cancer (NSCLC) or kidney cancer. The findings from the multicenter, phase IB study were published in Lancet Oncology.

    January 28, 2020
    Trastuzumab Biosimilar Has Comparative Safety and Efficacy After Long-Term Follow-Up
    Treatments

    Trastuzumab Biosimilar Has Comparative Safety and Efficacy After Long-Term Follow-Up

    January 22, 2020
    Breast Cancer Is More Fatal in Men Than Women
    Breast cancer

    Breast Cancer Is More Fatal in Men Than Women

    Men have higher death rates than women across all stages of breast cancer, study findings reported in JAMA Oncology show. In the study, five-year overall survival after a breast cancer diagnosis was 77.6% for men and 86.4% for women.

    January 15, 2020
    Comprehensive Tobacco Treatment Helps Almost Half of Patients Quit Smoking
    Cancer risk prevention

    Comprehensive Tobacco Treatment Helps Almost Half of Patients Quit Smoking

    After nine months of follow-up, 44% of patients in a comprehensive tobacco treatment program were compliant with smoking abstinence, according to the results of a study published in JAMA Network Open.

    January 08, 2020
    Does Cryotherapy Prevent Extremity Toxicities From Taxane Chemotherapy?
    Treatment side effects

    Does Cryotherapy Prevent Extremity Toxicities From Taxane Chemotherapy?

    As many as 50% of patients receiving taxane chemotherapy have reported experiencing peripheral neuropathy (PN) or nail changes during treatment. Both are potentially dose-limiting adverse events: nail changes can lead to infections; PN affects patients’ ability to perform activities of daily living and results in sensory impairments such as loss of balance, muscle weakness, and numbness that can increase patients’ risk for falls.

    January 07, 2020
    CAR T-Cell Therapy Offers Rapid QOL Improvements in Younger Patients
    Patient quality of life

    CAR T-Cell Therapy Offers Rapid QOL Improvements in Younger Patients

    Children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia reported rapid improvements in quality of life (QOL) after treatment with tisagenlecleucel, a CAR T-cell therapy, according to the results of a study published in Lancet Oncology.

    January 01, 2020
    Experts Recommend Tailored Exercise for All Cancer Treatment Plans
    Research

    Experts Recommend Tailored Exercise for All Cancer Treatment Plans

    Systemic use of exercise prescriptions not only lowers the risk of certain cancers but also helps to improve side effects and survival from cancer and should therefore be incorporated into cancer treatment plans, experts from the American College of Sports Medicine and 17 partner organizations said in articles published in Medicine and Science in Sports and Exercise and CA: A Cancer Journal for Clinicians.

    December 25, 2019
    Multigene Testing Is Cost Effective for All Women With Breast Cancer
    Genetics & genomics

    Multigene Testing Is Cost Effective for All Women With Breast Cancer

    According to findings from a new analysis published in JAMA Oncology, multigene testing should be expanded to all women with breast cancer and not just those with certain family histories or clinical factors.

    December 20, 2019
    Combining Tamoxifen and Blue Light Can Better Target CAR T Cells
    Research

    Combining Tamoxifen and Blue Light Can Better Target CAR T Cells

    Bioengineers may have found a way to use tamoxifen activated with blue light to control precisely which tissues and body areas CAR T cells attack, reducing toxicities in other parts of the body. They reported their work in ACS Synthetic Biology.

    December 18, 2019
    Head and Neck Melanoma Increases 51% in Young People
    Research

    Head and Neck Melanoma Increases 51% in Young People

    Incidence of melanoma in the head and neck areas increased 51.1% from 1995 to 2014, according to findings from a study published in JAMA Otolaryngology.

    December 11, 2019
    Evidence-Based Program Reduced C. Difficile Incidence in Patients With Cancer
    Clinical practice

    Evidence-Based Program Reduced C. Difficile Incidence in Patients With Cancer

    Clostridium difficile infection is a dangerous and sometimes deadly adverse event in immunocompromised patients with cancer. Although transmission risk is high in the hospital setting, even with isolation precautions, oncology providers can use a variety of prevention techniques to reduce the chance for infection in their patients.

    December 10, 2019
    CDK4/6 Plus AI Is Effective for Older Women With Breast Cancer
    Breast cancer

    CDK4/6 Plus AI Is Effective for Older Women With Breast Cancer

    Combination treatment with a CDK4/6 inhibitor and aromatase inhibitor (AI) results in similar progression-free survival (PFS) rates in women with hormone receptor-positive, HER2-negative metastatic breast cancer who are aged 70 or older compared to younger women, according to study findings published in the Journal of Clinical Oncology.

    December 04, 2019
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • …
    • Next page
    • Last page Last »
     
    picture of the author
    Elisa Becze BA, ELS, Editor
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2020 Oncology Nursing Society
     
    Back to Top ▲